Hanmi's Pidogle to benefit from health insurance

Published: 2008-05-26 06:57:00

Updated: 2008-05-26 06:57:00

The Health Insurance Review Agency's committee said on May 21 that Hanmi Pharm's Pidogle (clopidogrel bisulfate) will be eligible for health insurance following the company's request for a government price evaluation.

On March 21, two generic drugs of Plavix Chong Kun Dang Pharmaceutical's Pri...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK